ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
19 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
19
|
|
ASX - By Stock
|
MSB |
2022 let's look forward
|
|
yelrom
|
7 |
2.3K |
34 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
7
|
2.3K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
yelrom
|
850 |
251K |
9 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
251K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
yelrom
|
850 |
251K |
39 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
251K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
yelrom
|
850 |
251K |
69 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
251K
|
69
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
23 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CEO Presentation to 2021 Annual General Meeting
|
|
yelrom
|
54 |
17K |
16 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
54
|
17K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Chairman Message to 2021 AGM
|
|
yelrom
|
54 |
20K |
31 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
54
|
20K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility
|
|
yelrom
|
451 |
114K |
8 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
451
|
114K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility
|
|
yelrom
|
451 |
114K |
13 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
451
|
114K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility
|
|
yelrom
|
451 |
114K |
33 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
451
|
114K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
33 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
905
|
286K
|
33
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
21 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
10K
|
3.0M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Exiting Roche - Cas$$$ed Up
|
|
yelrom
|
128 |
39K |
56 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
128
|
39K
|
56
|
|
ASX - By Stock
|
MSB |
Re:
the shorts will bail with margin calling and announcements due
|
|
yelrom
|
482 |
122K |
47 |
06/11/21 |
06/11/21 |
ASX - By Stock
|
482
|
122K
|
47
|
|
ASX - By Stock
|
MSB |
Re:
CHF - MSB's Dark Horse with Multi-billion dollar potential
|
|
yelrom
|
516 |
156K |
27 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
516
|
156K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
19 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Near term catalyst discussion
|
|
yelrom
|
51 |
12K |
26 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
51
|
12K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
yelrom
|
4.7K |
1.1M |
0 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
yelrom
|
206 |
62K |
33 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
206
|
62K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
7 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
yelrom
|
1.0K |
418K |
30 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
1.0K
|
418K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
yelrom
|
1.5K |
504K |
11 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
1.5K
|
504K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Regulatory Pathways - where we stand with the FDA
|
|
yelrom
|
74 |
26K |
25 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
74
|
26K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
9.8K |
2.9M |
13 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
9.8K
|
2.9M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Another AFR Article - this time on the Angioblast deal
|
|
yelrom
|
98 |
24K |
18 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
98
|
24K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
9.8K |
2.9M |
7 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
9.8K
|
2.9M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
6 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
10K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
9 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
10K
|
3.0M
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
37 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
10K
|
3.0M
|
37
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial 90-Day Survival Outcomes Presented at ISCT
|
|
yelrom
|
251 |
91K |
26 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
251
|
91K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Respiratory Outcomes Presented
|
|
yelrom
|
163 |
61K |
7 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
163
|
61K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Respiratory Outcomes Presented
|
|
yelrom
|
163 |
61K |
41 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
163
|
61K
|
41
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
40 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
422
|
145K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
$90 a share on COVID ARDS Authorization ?
|
|
yelrom
|
260 |
81K |
15 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
260
|
81K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
yelrom
|
1.5K |
415K |
31 |
27/06/21 |
27/06/21 |
ASX - By Stock
|
1.5K
|
415K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
yelrom
|
1.5K |
504K |
23 |
26/06/21 |
26/06/21 |
ASX - By Stock
|
1.5K
|
504K
|
23
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
7 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
10K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
yelrom
|
1.5K |
504K |
7 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
1.5K
|
504K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Silviu 17th June - Stem cell summit notes
|
|
yelrom
|
68 |
28K |
17 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
68
|
28K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
2021.... Year of the boom ?
|
|
yelrom
|
346 |
109K |
21 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
346
|
109K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
yelrom
|
300 |
86K |
34 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
300
|
86K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Novartis tomorrow bout time
|
|
yelrom
|
57 |
23K |
10 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
57
|
23K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Novartis tomorrow bout time
|
|
yelrom
|
57 |
23K |
4 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
57
|
23K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Novartis tomorrow bout time
|
|
yelrom
|
57 |
23K |
39 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
57
|
23K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Bitter Pill
|
|
yelrom
|
246 |
85K |
32 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
246
|
85K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
yelrom
|
1.0K |
418K |
27 |
30/05/21 |
30/05/21 |
ASX - By Stock
|
1.0K
|
418K
|
27
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
30 |
29/05/21 |
29/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
18 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
17K
|
6.7M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COPD Published in Respiratory Research
|
|
yelrom
|
91 |
30K |
5 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
91
|
30K
|
5
|
|